Cancer-derived exosomal Alu RNA promotes colorectal cancer progression
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Inflammation plays a crucial role in cancer progression, but the relevance of the inflammasome remains unclear. Alu RNA was the first endogenous nucleic acid shown to activate the NLRP3 (nucleotide-binding domain leucine-rich repeat containing 3) inflammasome. Here, we showed that Alu RNA can induce epithelial-to-mesenchymal transition (EMT) through NLRP3 inflammasome activation and IL-1β release in colorectal cancer (CRC) cells. Alu RNA is stored, transported and transferred to CRC cells by exosomes. Exosomal Alu RNA promotes tumorigenesis by inducing invasion, metastasis and EMT via NLRP3 inflammasome activation. Consistent with these data, we found that significantly increased Alu RNA expression correlates with the induction of NLRP3 priming in human CRC patients. Furthermore, the level of Alu RNA in circulating exosomes correlates with CRC progression in a preclinical model. These findings reveal the direct involvement of Alu RNA in cancer pathogenesis, and its presence in CRC cell-derived exosomes could be used as a noninvasive diagnostic biomarker.
Abstract
Inflammation plays a crucial role in cancer progression, but the relevance of the inflammasome remains unclear. Alu RNA was the first endogenous nucleic acid shown to activate the NLRP3 (nucleotide-binding domain leucine-rich repeat containing 3) inflammasome. Here, we showed that Alu RNA can induce epithelial-to-mesenchymal transition (EMT) through NLRP3 inflammasome activation and IL-1β release in colorectal cancer (CRC) cells. Alu RNA is stored, transported and transferred to CRC cells by exosomes. Exosomal Alu RNA promotes tumorigenesis by inducing invasion, metastasis and EMT via NLRP3 inflammasome activation. Consistent with these data, we found that significantly increased Alu RNA expression correlates with the induction of NLRP3 priming in human CRC patients. Furthermore, the level of Alu RNA in circulating exosomes correlates with CRC progression in a preclinical model. These findings reveal the direct involvement of Alu RNA in cancer pathogenesis, and its presence in CRC cell-derived exosomes could be used as a noninvasive diagnostic biomarker.
참고문헌 (35)
- Deininger, P., "Alu elements : know the SINEs", Genome Biol, 12, pp.236~ (2011)
- Batzer, M. A., "Alu repeats and human genomic diversity", Nat Rev Genet, 3, pp.370~379 (2002)
- Häsler, J., "Useful ‘junk’ : Alu RNAs in the human tran scriptome", Cell Mol Life Sci, 64, pp.1793~1800 (2007)
- Burns, K. H., "Repetitive DNA in disease", Science, 376, pp.353~354 (2022)
- Kaneko, H., "DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration", Nature, 471, pp.325~330 (2011)
- Tarallo, V., "DICER1 loss and Alu RNA induce age-related macular degen eration via the NLRP3 inflammasome and MyD88", Cell, 149, pp.847~859 (2012)
- Hung, T., "The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression", Science, 350, pp.455~459 (2015)
- Ambati, J., "Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development", Nat Commun, 11, pp.4737~ (2020)
- Pascarella, G., "Recombination of repeat elements generates somatic com plexity in human genomes", Cell, 185, pp.3025~3040 (2022)
- Baryakin, D. N., "Alu-and 7SL RNA analogues suppress MCF-7 cell viability through modulating the transcription of endoplasmic reticulum stress response genes", Acta Nat, 5, pp.83~93 (2013)
- Sakamoto, K., "Mod ulation of HeLa cell growth by transfected 7SL RNA and Alu gene sequences", J Biol Chem, 266, pp.3031~3038 (1991)
- Zhao, Y., "Transposon-triggered innate immune response confers cancer resistance to the blind mole rat", Nat Immunol, 22, pp.1219~1230 (2021)
- Tang, R. -B., "Increased level of polymerase III transcribed Alu RNA in hepa tocellular carcinoma tissue", Mol Carcinog, 42, pp.93~96 (2005)
- Di Ruocco, F., "Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression", Oncogene, 37, pp.627~637 (2018)
- Balaj, L., "Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences", Nat Commun, 2, pp.180~ (2011)
- Kantono, M., "Inflammasomes and cancer : the dynamic role of the inflammasome in tumor development", Front Immunol, 8, pp.1132~ (2017)
- Schroder, K., "The inflammasomes", Cell, 140, pp.821~832 (2010)
- Marandi, Y., "NLRP3-inflammasome activation is associated with epithelial mesenchymal transition and progression of colorectal cancer", Iran J Basic MedSci, 24, pp.483~492 (2021)
- Shao, X., "NLRP3 promotes colorectal cancer cell proliferation and metastasis via regulating epithelial mesenchymal transformation", Anticancer Agents Med Chem, 20, pp.820~827 (2020)
- Li, R., "Chronic IL-1β-induced inflammation regulates epithelial-to mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer", Sci Rep, 10, pp.377~ (2020)
- Li, Y., "IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation", Mol Cancer, 11, pp.87~ (2012)
- Tulotta, C., "Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment", Clin Cancer Res, 25, pp.2769~2782 (2019)
- Marchetti, C., "OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflam mation", Proc Natl Acad Sci USA, 115, pp.E1530~E1539 (2018)
- Cullen, S. P., "Diverse activators of the NLRP3 inflammasome promote IL-1β secretion by triggering Necrosis", Cell Rep, 11, pp.1535~1548 (2015)
- Fink, S. L., "Caspase-1-dependent pore formation during pyr optosis leads to osmotic lysis of infected host macrophages", Cell Microbiol, 8, pp.1812~1825 (2006)
- Conos, S. A., "Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion", Cell Death Differ, 23, pp.1827~1838 (2016)
- Kerur, N., "TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy", Invest Ophthalmol Vis Sci, 54, pp.7395~7401 (2013)
- Zaki,M.H., "TheNLRP3inflammasome protects against loss of epithelial integrity and mortality during experimental colitis", Immunity, 32, pp.379~391 (2010)
- Ungerbäck, J., "Genetic variation and alterations of genes involved in NFκB", TNFAIP3-and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer, 2012, pp.33, 2126~2134
- Rajurkar, M., "Reverse transcriptase inhibition disrupts repeat element life cycle in colorectal cancer", Cancer Discov, 12, pp.1462~1481 (2022)
- Fowler, B. J., "Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity", Science, 346, pp.1000~1003 (2014)
- Ambati, M., "Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration", Proc Natl Acad Sci USA, 118, pp.e2102975118~ (2021)
- Magagnoli, J., "Association between Fluoxetine use and overall survival among patients with cancer treated with PD-1", L1 immunotherapy, 2023, pp.16, 640~
- Becker, A., "Extracellular vesicles in cancer : cell-to-cell mediators of metas tasis", Cancer Cell, 30, pp.836~848 (2016)
- Wortzel, I., "Exosome-mediated metastasis:communication from a distance", Dev. Cell, 49, pp.347~360 (2019)